文献速递物质与行为成瘾

磷脂酰乙醇的DNA甲基化特征而非自报饮酒量可预测有害饮酒

DNA methylation signature on phosphatidylethanol, not on self-reported alcohol consumption, predicts hazardous alcohol consumption in two distinct populations.
PubMed 文献 · Mol Psychiatry · 2020-02-07

在两个人群(Ntotal=1549)中,基于磷脂酰乙醇(PEth)的EWAS识别出83个相关CpG,而自报饮酒量无CpG达全基因组显著。从PEth-EWAS选出的143个CpG子集预测有害饮酒(HAD)在验证集AUC为73.9%,自报饮酒量选出的CpG子集验证集AUC仅57.6%。

要点

  • PEth的EWAS识别83个CpG,自报饮酒量无CpG达全基因组显著。
  • PEth来源143个CpG子集预测HAD验证集AUC 73.9%。
  • 自报饮酒量来源CpG子集预测HAD验证集AUC 57.6%。

核心结论

  • 客观饮酒指标PEth比自报数据更能揭示表观遗传机制,其DNAm特征可作为饮酒的稳健生物标志物。

研究设计与样本

  • 在两个人口学和临床特征不同的人群(Ntotal=1549)中,分别对PEth和自报饮酒量进行EWAS,并用机器学习方法在独立队列中测试CpG子集对HAD的预测。

主要发现

  • 队列1中PEth的EWAS识别出83个相关CpG,其中23个先前与饮酒或酒精使用障碍相关。
  • 自报饮酒量的EWAS无CpG达到全基因组显著性。
  • 从PEth-EWAS选出的143个CpG子集预测HAD,训练集AUC 89.4%,验证集AUC 73.9%。
  • 从自报饮酒量EWAS预选的CpG预测HAD,训练集AUC 75.2%,验证集AUC 57.6%。

关键数值与推荐

  • PEth相关CpG子集(143个)预测HAD验证集AUC为73.9%。
  • 自报饮酒量相关CpG子集预测HAD验证集AUC为57.6%。

临床怎么用

  • 血液PEth相关DNAm特征可作为客观生物标志物辅助临床评估有害饮酒。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The process of diagnosing hazardous alcohol drinking (HAD) is based on self-reported data and is thereby vulnerable to bias. There has been an interest in developing epigenetic biomarkers for HAD that might complement clinical assessment. Because alcohol consumption has been previously linked to DNA methylation (DNAm), we aimed to select DNAm signatures in blood to predict HAD from two demographically and clinically distinct populations (Ntotal = 1,549). We first separately conducted an epigenome-wide association study (EWAS) for phosphatidylethanol (PEth), an objective measure of alcohol consumption, and for self-reported alcohol consumption in Cohort 1. We identified 83 PEth-associated CpGs, including 23 CpGs previously associated with alcohol consumption or alcohol use disorder. In contrast, no CpG reached epigenome-wide significance on self-reported alcohol consumption. Using a machine learning approach, two CpG subsets from EWAS on PEth and on self-reported alcohol consumption from Cohort 1 were separately tested for the prediction of HAD in Cohort 2. We found that a subset of 143 CpGs selected from the EWAS on PEth showed an excellent prediction of HAD with the area under the receiver operating characteristic curve (AUC) of 89.4% in training set and 73.9% in validation set of Cohort 2. However, CpGs preselected from the EWAS on self-reported alcohol consumption showed a poor prediction of HAD with AUC 75.2% in training set and 57.6% in validation set. Our results demonstrate that an objective measure for alcohol consumption is a more informative phenotype than self-reported data for revealing epigenetic mechanisms. The PEth-associated DNAm signature in blood could serve as a robust biomarker for alcohol consumption.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Liang X, Justice AC, So-Armah K, et al. DNA methylation signature on phosphatidylethanol, not on self-reported alcohol consumption, predicts hazardous alcohol consumption in two distinct populations. Mol Psychiatry. 2020. PMID: 32034291. doi:10.1038/s41380-020-0668-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。